{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:31:35Z","timestamp":1785843095844,"version":"3.56.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Age-related cardiovascular diseases (CVDs) remain among the leading global causes of death, and vascular smooth muscle cell (VSMC) remodeling plays an essential role in its pathology. Reduced NO-cGMP pathway signaling is a major feature and pathogenic mechanism underlying vasodilator dysfunction. Recently, we identified phosphodiesterase (PDE) 1, an enzyme that hydrolyzes and inactivates the cyclic nucleotides <jats:ext-link>cAMP<\/jats:ext-link> and <jats:ext-link>cGMP<\/jats:ext-link>, and thereby provides a potential treatment target for restoring age-related vascular dysfunction due to aging of VSMC. Based on this hypothesis, we here tested the effects of PDE1 inhibition in a model of SMC-specific accelerated aging mice. SMC-KO and their WT littermates received either vehicle or the PDE1 inhibitor lenrispodun for 8\u00a0weeks. Vascular function was measured both <jats:italic>in vivo<\/jats:italic> (Laser Doppler technique) and <jats:italic>ex vivo<\/jats:italic> (organ bath). Moreover, we deployed UV irradiation in cell culture experiments to model accelerated aging in an <jats:italic>in vitro<\/jats:italic> situation. SMC-KO mice display a pronounced loss of vasodilator function in the isolated aorta, the cutaneous microvasculature, and mesenteric arteries. <jats:italic>Ex vivo<\/jats:italic>, in isolated vascular tissue, we found that PDE1 inhibition with lenrispodun improves vasodilation, while no improvement was observed in isolated aorta taken from mice after chronic treatment <jats:italic>in vivo<\/jats:italic>. However, during lenrispodun treatment <jats:italic>in vivo<\/jats:italic>, an enhanced microvascular response in association with upregulated cGMP levels was seen. Further, chronic lenrispodun treatment decreased TNF-\u03b1 and IL-10 plasma levels while the elevated level of IL-6 in SMC-KO mice remained unchanged after treatment. PDE1 and senescence markers, <jats:italic>p16<\/jats:italic> and <jats:italic>p21<\/jats:italic>, were increased in both SMC-KO aorta and cultured human VSMC in which DNA was damaged by ultraviolet irradiation. This increase was lowered by chronic lenrispodun. In contrast, lenrispodun increased the level of PDE1A in both situations. In conclusion, we demonstrated that PDE1 inhibition may be therapeutically useful in reversing aspects of age-related VSMC dysfunction by potentiating NO-cGMP signaling, preserving microvascular function, and decreasing senescence. Yet, after chronic treatment, the effects of PDE1 inhibition might be counteracted by the interplay between differential PDE1A and C expression. These results warrant further pharmacodynamic profiling of PDE enzyme regulation during chronic PDE1 inhibitor treatment.<\/jats:p>","DOI":"10.3389\/fphar.2021.818355","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:19:18Z","timestamp":1643606358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The Effects of Acute and Chronic Selective Phosphodiesterase 1 Inhibition on Smooth Muscle Cell-Associated Aging Features"],"prefix":"10.3389","volume":"12","author":[{"given":"Keivan","family":"Golshiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan Ataei","family":"Ataabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika A.","family":"J\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M","family":"Garrelds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P. J.","family":"Leijten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J. M.","family":"Roks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","article-title":"Nitric Oxide-cGMP Signaling in Hypertension: Current and Future Options for Pharmacotherapy","volume":"76","author":"Ataabadi","year":"2020","journal-title":"Hypertension"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2308317","DOI":"10.1155\/2021\/2308317","article-title":"Vascular Ageing Features Caused by Selective DNA Damage in Smooth Muscle Cell","volume":"2021","author":"Ataabadi","year":"2021","journal-title":"Oxid Med. Cel Longev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","article-title":"A Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker Development","volume":"18","author":"Basisty","year":"2020","journal-title":"Plos Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1042\/CS20140753","article-title":"Phosphodiesterase 1 Regulation Is a Key Mechanism in Vascular Aging","volume":"129","author":"Bautista Ni\u00f1o","year":"2015","journal-title":"Clin. Sci. (Lond)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/ijms17050748","article-title":"DNA Damage: A Main Determinant of Vascular Aging","volume":"17","author":"Bautista-Ni\u00f1o","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1042\/CS20190124","article-title":"Local Endothelial DNA Repair Deficiency Causes Aging-Resembling Endothelial-specific Dysfunction","volume":"134","author":"Bautista-Ni\u00f1o","year":"2020","journal-title":"Clin. Sci. (Lond)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.3390\/ijms22052593","article-title":"Phosphodiesterases Expression during Murine Cardiac Development","volume":"22","author":"Carvalho","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/cells9030656","article-title":"Vascular Smooth Muscle Cell-specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment","volume":"9","author":"Del Campo","year":"2020","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.3402\/pba.v1i0.7219","article-title":"Broad Segmental Progeroid Changes in Short-Lived Ercc1(-\/\u03947) Mice","volume":"1","author":"Doll\u00e9","year":"2011","journal-title":"Pathobiol Aging Age Relat. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1161\/CIRCULATIONAHA.112.104380","article-title":"Nucleotide Excision DNA Repair Is Associated with Age-Related Vascular Dysfunction","volume":"126","author":"Durik","year":"2012","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7156435","DOI":"10.1155\/2018\/7156435","article-title":"Aging-Induced Biological Changes and Cardiovascular Diseases","volume":"2018","author":"Fajemiroye","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.3390\/molecules23123205","article-title":"Function and Interactions of ERCC1-XPF in DNA Damage Response","volume":"23","author":"Faridounnia","year":"2018","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: Chronic Inflammation in Ageing, Cardiovascular Disease, and Frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e008236","DOI":"10.1161\/circheartfailure.120.008236","article-title":"Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition with ITI-214 in Human Systolic Heart Failure","volume":"14","author":"Gilotra","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bcpt.13319","article-title":"The Importance of the Nitric Oxide-cGMP Pathway in Age-Related Cardiovascular Disease: Focus on Phosphodiesterase-1 and Soluble Guanylate Cyclase","volume":"127","author":"Golshiri","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.3390\/ijms21134667","article-title":"Chronic Sildenafil Treatment Improves Vasomotor Function in a Mouse Model of Accelerated Aging","volume":"21","author":"Golshiri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1124\/jpet.121.000628","article-title":"Selective PDE1 Inhibition Ameliorates Vascular Function, Reduces Inflammatory Response, and Lowers Blood Pressure in Ageing Animals","volume":"380","author":"Golshiri","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1161\/CIRCULATIONAHA.117.030490","article-title":"Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition","volume":"138","author":"Hashimoto","year":"2018","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.3390\/ijms20225694","article-title":"The Role of Vascular Smooth Muscle Cells in Arterial Remodeling: Focus on Calcification-Related Processes","volume":"20","author":"Jaminon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1111\/bph.14034","article-title":"PDE1A Inhibition Elicits cGMP-dependent Relaxation of Rat Mesenteric Arteries","volume":"174","author":"Khammy","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1161\/hc4401.098432","article-title":"Upregulation of Phosphodiesterase 1A1 Expression Is Associated with the Development of Nitrate Tolerance","volume":"104","author":"Kim","year":"2001","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E7116","DOI":"10.1073\/pnas.1607728113","article-title":"PDE1C Deficiency Antagonizes Pathological Cardiac Remodeling and Dysfunction","volume":"113","author":"Knight","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/ani9090623","article-title":"A Review of Endothelium-dependent and -Independent Vasodilation Induced by Phytochemicals in Isolated Rat Aorta","volume":"9","author":"Knox","year":"2019","journal-title":"Animals (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/01.cir.0000048892.83521.58","article-title":"Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part I: Aging Arteries: a \"set up\" for Vascular Disease","volume":"107","author":"Lakatta","year":"2003","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/jcdd5020020","article-title":"cGMP Signaling and Vascular Smooth Muscle Cell Plasticity","volume":"5","author":"Lehners","year":"2018","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fcvm.2018.00012","article-title":"Source of Chronic Inflammation in Aging","volume":"5","author":"Sanada","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s00213-016-4346-2","article-title":"Preclinical Profile of ITI-214, an Inhibitor of Phosphodiesterase 1, for Enhancement of Memory Performance in Rats","volume":"233","author":"Snyder","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory Cytokines in Vascular Dysfunction and Vascular Disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7092151","DOI":"10.1155\/2019\/7092151","article-title":"Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease","volume":"2019","author":"Steven","year":"2019","journal-title":"Oxidative Med. Cell Longevity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41569-020-0431-7","article-title":"Ageing and Atherosclerosis: Vascular Intrinsic and Extrinsic Factors and Potential Role of IL-6","volume":"18","author":"Tyrrell","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-pharmtox-010814-124316","article-title":"Genome Integrity in Aging: Human Syndromes, Mouse Models, and Therapeutic Options","volume":"56","author":"Vermeij","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5339\/gcsp.2014.43","article-title":"Endothelial Dysfunction and Cardiovascular Disease","volume":"2014","author":"Widmer","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1042\/CS20170026","article-title":"Dietary Restriction but Not Angiotensin II Type 1 Receptor Blockade Improves DNA Damage-Related Vasodilator Dysfunction in Rapidly Aging Ercc1\u0394\/- Mice","volume":"131","author":"Wu","year":"2017","journal-title":"Clin. Sci. (Lond)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1271\/bbb.67.973","article-title":"cGMP-phosphodiesterase Activity Is Up-Regulated in Response to Pressure Overload of Rat Ventricles","volume":"67","author":"Yanaka","year":"2003","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e62852","DOI":"10.7554\/eLife.62852","article-title":"DNA Damage-How and Why We Age?","volume":"10","author":"Yousefzadeh","year":"2021","journal-title":"Elife"},{"key":"B36","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","article-title":"An Aged Immune System Drives Senescence and Ageing of Solid Organs","volume":"594","author":"Yousefzadeh","year":"2021","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1111\/bph.14651","article-title":"Cyclic Nucleotide Signalling Compartmentation by PDEs in Cultured Vascular Smooth Muscle Cells","volume":"176","author":"Zhang","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2107898118","DOI":"10.1073\/pnas.2107898118","article-title":"Cyclic Nucleotide Phosphodiesterase 1C Contributes to Abdominal Aortic Aneurysm","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U S A."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.818355\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:19:21Z","timestamp":1643606361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.818355\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":38,"alternative-id":["10.3389\/fphar.2021.818355"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.818355","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"article-number":"818355"}}